XML 61 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Cash, Cash Equivalents, and Marketable Securities (Notes)
9 Months Ended
Sep. 30, 2017
Fair Value Disclosures [Abstract]  
CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES
CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES

The fair values of cash, cash equivalents, and marketable securities measured at fair value on a recurring basis on our balance sheet were as follows (in millions):
 
 
 
December 31, 2016
 
Fair Value
 Level
 
Automotive
 
Financial Services
 
All
Other
 
Consolidated
Cash and cash equivalents
 
 
 
 
 
 
 
 
 
U.S. government
1
 
$
888

 
$
924

 
$

 
$
1,812

U.S. government agencies
2
 

 

 

 

Non-U.S. government and agencies
2
 
200

 
142

 

 
342

Corporate debt
2
 
100

 

 

 
100

Total marketable securities classified as cash equivalents
 
 
1,188

 
1,066

 

 
2,254

Cash, time deposits, and money market funds
 
 
6,632

 
7,011

 
8

 
13,651

Total cash and cash equivalents
 
 
$
7,820

 
$
8,077

 
$
8

 
$
15,905

 
 
 
 
 
 
 
 
 
 
Marketable securities
 
 
 
 
 
 
 
 
 
U.S. government
1
 
$
8,099

 
$
1,634

 
$

 
$
9,733

U.S. government agencies
2
 
2,244

 
505

 

 
2,749

Non-U.S. government and agencies
2
 
4,751

 
632

 

 
5,383

Corporate debt
2
 
4,329

 
475

 

 
4,804

Equities
1
 
165

 

 

 
165

Other marketable securities
2
 
54

 
34

 

 
88

Total marketable securities
 
 
$
19,642

 
$
3,280

 
$

 
$
22,922

 
 
 
 
 
 
 
 
 
 
 
 
 
September 30, 2017
 
Fair Value
 Level
 
Automotive
 
Financial Services
 
All
Other
 
Consolidated
Cash and cash equivalents
 
 
 
 
 
 
 
 
 
U.S. government
1
 
$
498

 
$
112

 
$

 
$
610

U.S. government agencies
2
 
150

 
200

 

 
350

Non-U.S. government and agencies
2
 

 
357

 

 
357

Corporate debt
2
 

 

 

 

Total marketable securities classified as cash equivalents
 
 
648

 
669

 

 
1,317

Cash, time deposits, and money market funds
 
 
8,105

 
8,166

 
1

 
16,272

Total cash and cash equivalents
 
 
$
8,753

 
$
8,835

 
$
1

 
$
17,589

 
 
 
 
 
 
 
 
 
 
Marketable securities
 
 
 
 
 
 
 
 
 
U.S. government
1
 
$
4,418

 
$
670

 
$

 
$
5,088

U.S. government agencies
2
 
2,990

 
384

 

 
3,374

Non-U.S. government and agencies
2
 
5,833

 
971

 

 
6,804

Corporate debt
2
 
3,958

 
1,051

 

 
5,009

Equities
1
 
160

 

 

 
160

Other marketable securities
2
 
32

 
25

 

 
57

Total marketable securities
 
 
$
17,391

 
$
3,101

 
$

 
$
20,492



NOTE 7. CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES (Continued)

The cash equivalents and marketable securities accounted for as available-for-sale (“AFS”) securities on our balance sheet were as follows (in millions):
 
December 31, 2016
 
 
 
 
 
 
 
 
 
Fair Value of Securities with
Contractual Maturities
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
 
Within 1 Year
 
After 1 Year through 5 Years
 
After 5 Years through 10 Years
Automotive
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. government
$
3,703

 
$
2

 
$
(14
)
 
$
3,691

 
$
727

 
$
2,776

 
$
188

U.S. government agencies
308

 

 
(2
)
 
306

 

 
306

 

Non-U.S. government and agencies
1,443

 
1

 
(11
)
 
1,433

 
148

 
1,285

 

Corporate debt
1,079

 

 

 
1,079

 
1,031

 
48

 

Total
$
6,533

 
$
3

 
$
(27
)
 
$
6,509

 
$
1,906

 
$
4,415

 
$
188

 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
September 30, 2017
 
 
 
 
 
 
 
 
 
Fair Value of Securities with
Contractual Maturities
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
 
Within 1 Year
 
After 1 Year through 5 Years
 
After 5 Years through 10 Years
Automotive
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. government
$
3,228

 
$

 
$
(8
)
 
$
3,220

 
$
1,268

 
$
1,952

 
$

U.S. government agencies
1,795

 

 
(5
)
 
1,790

 
228

 
1,547

 
15

Non-U.S. government and agencies
3,392

 
6

 
(7
)
 
3,391

 
99

 
3,242

 
50

Corporate debt
1,542

 
1

 
(1
)
 
1,542

 
530

 
1,012

 

Total
$
9,957

 
$
7

 
$
(21
)
 
$
9,943

 
$
2,125

 
$
7,753

 
$
65



Sales proceeds from investments classified as AFS and sold prior to maturity were $0 and $491 million in the third quarter of 2016 and 2017, respectively, and $69 million and $3.1 billion in the first nine months of 2016 and 2017, respectively. Gross realized gains from the sale of AFS securities in both the third quarter of 2016 and 2017 were $0, and in the first nine months of 2016 and 2017 were $1 million and $3 million, respectively. Gross realized losses from the sale of AFS securities in both the third quarter of 2016 and 2017 were $0, and in the first nine months of 2016 and 2017 were $0 and $8 million, respectively.

NOTE 7. CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES (Continued)

The present fair values and gross unrealized losses for cash equivalents and marketable securities accounted for as AFS securities that were in an unrealized loss position, aggregated by investment category and the length of time that individual securities have been in a continuous loss position, were as follows (in millions):
 
December 31, 2016
 
Less than 1 year
 
1 Year or Greater
 
Total
 
Fair Value
 
Unrealized Losses
 
Fair Value
 
Unrealized Losses
 
Fair Value
 
Unrealized Losses
 
 
 
 
 
 
 
 
 
 
 
 
Automotive
 
 
 
 
 
 
 
 
 
 
 
U.S. government
$
1,474

 
$
(14
)
 
$

 
$

 
$
1,474

 
$
(14
)
U.S. government agencies
261

 
(2
)
 

 

 
261

 
(2
)
Non-U.S. government and agencies
1,137

 
(11
)
 

 

 
1,137

 
(11
)
Corporate debt

 

 

 

 

 

Total
$
2,872

 
$
(27
)
 
$

 
$

 
$
2,872

 
$
(27
)
 
 

 
 
 
 
 
 
 
 
 
 
 
September 30, 2017
 
Less than 1 year
 
1 Year or Greater
 
Total
 
Fair Value
 
Unrealized Losses
 
Fair Value
 
Unrealized Losses
 
Fair Value
 
Unrealized Losses
Automotive
 
 
 
 
 
 
 
 
 
 
 
U.S. government
$
2,674

 
$
(7
)
 
$
49

 
$
(1
)
 
$
2,723

 
$
(8
)
U.S. government agencies
1,608

 
(4
)
 
49

 
(1
)
 
1,657

 
(5
)
Non-U.S. government and agencies
1,956

 
(7
)
 
39

 

 
1,995

 
(7
)
Corporate debt
543

 
(1
)
 

 

 
543

 
(1
)
Total
$
6,781

 
$
(19
)
 
$
137

 
$
(2
)
 
$
6,918

 
$
(21
)


We determine other-than-temporary impairments on cash equivalents and marketable securities using a specific identification method. During the nine months ended September 30, 2016 and 2017, we did not recognize any other-than-temporary impairment loss.

Other Securities

Investments in entities that we do not control and over which we do not have the ability to exercise significant influence are recorded at cost and reported in Other assets in the non-current assets section of our consolidated balance sheet. These cost method investments were $219 million and $326 million at December 31, 2016 and September 30, 2017, respectively.